J&J's Sudden Talc-Cancer Settlements Aren't Its Usual Style

  • Oklahoma, California, New York suits all settled same day
  • J&J says no global settlement eyed for baby-powder cases

Photographer: Scott Eells/Bloomberg

Lock
This article is for subscribers only.

Johnson & Johnson took the unusual step of settling three women’s claims that its talc-based products caused their asbestos-linked cancers rather than let juries decide the cases, potentially opening a new front in the growing litigation against the world’s largest maker of health-care products.

Jurors in state court in Oklahoma City Wednesday spent about three hours weighing whether J&J’s baby powder was a factor in a 77-year-old woman’s development of peritoneal mesothelioma when a judge announced the two sides had cut a deal. Details of the accord weren’t made public.